Three of the most stubborn and dangerous healthcare-associated infections are on the rise in acute care settings across the country, according to the Leapfrog Group, which published its spring 2023 Hospital Safety Grades on Wednesday.
WHY IT MATTERSData from the new Leapfrog report show…
Source: Healthcareitnews.com and Read More
FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or
